FI923723L - 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat - Google Patents

4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat Download PDF

Info

Publication number
FI923723L
FI923723L FI923723A FI923723A FI923723L FI 923723 L FI923723 L FI 923723L FI 923723 A FI923723 A FI 923723A FI 923723 A FI923723 A FI 923723A FI 923723 L FI923723 L FI 923723L
Authority
FI
Finland
Prior art keywords
hydroxiphenyl
triazol
piperazinyl
phenyl
derivatives
Prior art date
Application number
FI923723A
Other languages
English (en)
Other versions
FI923723A7 (fi
FI923723A0 (fi
Inventor
Jan Heeres
Joseph Hector Mostmans
Johan Rene Mark Beetens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI923723A0 publication Critical patent/FI923723A0/fi
Publication of FI923723A7 publication Critical patent/FI923723A7/fi
Publication of FI923723L publication Critical patent/FI923723L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI923723A 1991-09-13 1992-08-19 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat FI923723L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91202351 1991-09-13

Publications (3)

Publication Number Publication Date
FI923723A0 FI923723A0 (fi) 1992-08-19
FI923723A7 FI923723A7 (fi) 1993-03-14
FI923723L true FI923723L (fi) 1993-03-14

Family

ID=8207873

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923723A FI923723L (fi) 1991-09-13 1992-08-19 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat

Country Status (15)

Country Link
US (1) US5254553A (fi)
EP (1) EP0532091A1 (fi)
JP (1) JPH05194436A (fi)
KR (1) KR930006009A (fi)
CN (1) CN1071420A (fi)
AU (1) AU652069B2 (fi)
BG (1) BG96815A (fi)
CA (1) CA2076257A1 (fi)
FI (1) FI923723L (fi)
HU (1) HUT62884A (fi)
IL (1) IL102863A (fi)
MX (1) MX9205186A (fi)
NO (1) NO923532L (fi)
NZ (1) NZ244297A (fi)
ZA (1) ZA926967B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW279864B (fi) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
CZ287596A3 (en) * 1994-04-06 1997-01-15 Janssen Pharmaceutica Nv Ester carbamic derivatives of azolones, process of their preparation and the use of a composition in which the derivatives are comprised as well as process for preparing such composition
US5607932A (en) * 1994-07-12 1997-03-04 Janssen Pharmaceutica N.V. Heterocyclic derivatives of azolones
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MX2013003633A (es) * 2010-10-01 2013-04-24 Taisho Pharmaceutical Co Ltd Derivado de 1, 2, 4-triazolona.
KR101715448B1 (ko) * 2014-07-16 2017-03-20 주식회사 큐리언트 염증성 질환 치료용 화합물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols

Also Published As

Publication number Publication date
FI923723A7 (fi) 1993-03-14
NO923532D0 (no) 1992-09-11
FI923723A0 (fi) 1992-08-19
NO923532L (no) 1993-03-15
EP0532091A1 (en) 1993-03-17
JPH05194436A (ja) 1993-08-03
AU652069B2 (en) 1994-08-11
IL102863A0 (en) 1993-01-31
ZA926967B (en) 1994-03-11
CN1071420A (zh) 1993-04-28
IL102863A (en) 1996-05-14
BG96815A (bg) 1993-12-24
CA2076257A1 (en) 1993-03-14
US5254553A (en) 1993-10-19
MX9205186A (es) 1993-03-01
HU9202914D0 (en) 1992-11-30
AU2281992A (en) 1993-03-18
KR930006009A (ko) 1993-04-20
NZ244297A (en) 1994-03-25
HUT62884A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
FI943164L (fi) 2-(1-(1,3-tiatsolin-2-yyli)atsetidin-3-yyli)tiokarbapeneemijohdannaisia
NO910368L (no) Triazol-derivater.
PT1123287E (pt) 1-(piridil substituido)-1,2,4-triazoles insecticidas
FI914163L (fi) Heterocykliska derivat.
DE69226449D1 (de) 2-(2,6-difluorphenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-axazoline
FI922481L (fi) Heterocykliska derivat
DE69202721D1 (de) Substituierte Indenylverbindungen.
MA24171A1 (fr) Dihydrates de mesylate de 5- (2- (4-(1,2-benzisothiazole-3-yl) -1-piperazinyl)ethyl) -6-chloro-1,3-dihydro-2h-indole-2-one
FI930429A7 (fi) Uusia 1,4-dihydropyridiinijohdannaisia
FI910750A7 (fi) Heterocykliska foereningar.
FI920121L (fi) Foerfarande foer framstaellning av heterocykliska hydroxylaminer.
FI952682A0 (fi) Insektisidisiä 5-substituoituja 2,4-diamiinipyrimidiinijohdannaisia
FI914910L (fi) Heterocykliska foereningar.
FI923723L (fi) 4-(4-(4-(-hydroxifenyl)-1-piperazinyl)fenyl)-5-metyl-3h-1,2,4-triazol-3-on derivat
FI914906L (fi) 1-(3,4-dihydro-2-oxo-1h-kinolin-6-yl) -2-(4-(2-fenyletyl) piperidin-1-yl)etanol och -etanon, deras framstaellning och anvaendning inom terapi.
FI923392A0 (fi) Foerfarande foer framstaellning av 2-(imidazol-1-yl)-2-bensyletyliden-aminoxialkansyraderivat.
FI911983L (fi) Foerbaettrat foerfarande foer framstaellning av n-/3-(1h-imidazol-1-yl)fenyl/-4-(substituerad)-2 -pyrimidinaminer.
NO933170D0 (no) Heterocykliske forbindelser
FI915056A7 (fi) Substituoidut 1-(alkoksi-iminoalkyyli)imidatsoli-johdannaiset
FI910748A7 (fi) Heterocykliska foereningar.
FI932996A7 (fi) Heterocykliska foereningar
FI933900A7 (fi) Heterosykliset yhdisteet
FI915408L (fi) Foerfarande faer framstaellning av ett 4-hydroxistyrensalt och framstaellning av 4-(tertiaer butoxi) karbonyloxistyren daerav.
NZ238398A (en) 1-aryl-1,2-(optionally substituted)-3-(pyridin-3-yl)propane derivatives; fungicides

Legal Events

Date Code Title Description
FD Application lapsed